Clinical trials
Strabismus trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 4 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 6 |
| Unknown status | 3 |
| Withdrawn | 1 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 7 |
| Rebiscan, Inc. | 5 |
| Alaska Blind Child Discovery | 3 |
| Jaeb Center for Health Research | 3 |
| Boston Children's Hospital | 2 |
| Duke University | 2 |
| Massachusetts Eye and Ear Infirmary | 2 |
| Ochsner Health System | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Strabismus | 37 |
| Amblyopia | 18 |
| Ocular Motility Disorders | 5 |
| Exotropia | 4 |
| Anisometropia | 3 |
| Cataract | 3 |
| Diplopia | 3 |
| Emergence Delirium | 3 |
| Esotropia | 3 |
| Nystagmus, Pathologic | 3 |
Trials
Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.